# Gila Therapeutics, Inc. — Form D

Gila Therapeutics, Inc. of Edina, MN, a company, filed a Form D exempt-offering notice with the SEC on 2017-02-13. The offering totals $500K. Industry: Biotechnology.

## Offering

- Filed: 2017-02-13
- Form: D
- Accession: 0001209191-17-009965
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $500K
- Remaining: $500K
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-280594

## Issuer

- Name: Gila Therapeutics, Inc.
- CIK: 0001673503
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 5420 Highwood Drive West, Edina, MN, 55436
- Phone: 612-805-9054

## Officers, directors & promoters (23)

| Name | Role | Location |
| --- | --- | --- |
| Praveen Tyle | Director | Encinitas, CA |
| Jon Freeman | Executive Officer | Santa Clara, CA |
| Timothy Barberich | Director | Edina, MN |
| Christopher De Souza | Director | Charlotte, NC |
| Thomas Vasicek | Executive Officer | Edina, MN |
| Richard Horan | Director | Edina, MN |
| Scott Schorer | Director | Edina, MN |
| Scott Schorer | Executive Officer | Edina, MN |
| Sangeeta Kashyap | Executive Officer | Edina, MN |
| Tom Vasicek | Executive Officer | Minneapolis, MN |
| Richard J Horan | Director | Minneapolis, MN |
| Thomas J Vasicek | Director | Minneapolis, MN |
| Thomas J Vasicek | Executive Officer | Minneapolis, MN |
| Thomas J Vasicek | Promoter | Minneapolis, MN |
| Christopher J de Souza | Director | Minneapolis, MN |
| Jon J Freeman | Executive Officer | Minneapolis, MN |
| Christopher J DeSouza | Director | Minneapolis, MN |
| Andres J Acosta | Promoter | Minneapolis, MN |
| Sergei J Zolutukhin | Promoter | Minneapolis, MN |
| Richard R Horan | Director | Minneapolis, MN |
| Jon R Freeman | Executive Officer | Minneapolis, MN |
| Christopher R DeSouza | Director | Minneapolis, MN |
| Michael R Cardenas | Promoter | Minneapolis, MN |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-12-06](https://search.stillhousedata.com/formd/0001673503-23-000001) | D | $10.0M | $400K |
| [2022-11-29](https://search.stillhousedata.com/formd/0001673503-22-000001) | D | $5.0M | $356K |
| [2021-11-12](https://search.stillhousedata.com/formd/0001673503-21-000001) | D/A | $1.3M | $1.3M |
| [2021-02-16](https://search.stillhousedata.com/formd/0001437749-21-002956) | D | $500K | $402K |
| [2019-03-13](https://search.stillhousedata.com/formd/0001437749-19-004739) | D | $2.0M | $314K |
| [2017-04-18](https://search.stillhousedata.com/formd/0001209191-17-027327) | D/A | $4.0M | $3.3M |
| [2016-05-02](https://search.stillhousedata.com/formd/0001209191-16-116749) | D | $3.2M | $2.6M |

## More

- [CIK 1673503 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1673503&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001209191-17-009965.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.